Lupin acquires Nanomi B.V.

03 Feb 2014 Evaluate

Pharmaceutical major Lupin has acquired Netherlands-based Nanomi B.V. With this acquisition, the company has made its foray into the technology intensive complex injectables space.

Nanomi has patented technology platforms to develop complex injectable products. Nanomi has a rich talent pool of scientists who would be backed by Lupin’s global R&D and manufacturing teams.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally. The company reported 18.97% rise in its net profit at Rs 533.38 crore for the quarter as compared to Rs 448.30 crore for the same quarter in the previous year.

Lupin Share Price

2125.65 -21.95 (-1.02%)
28-Jan-2026 14:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1605.30
Dr. Reddys Lab 1222.00
Cipla 1318.90
Zydus Lifesciences 890.95
Lupin 2125.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×